Net Loss of OneSource Specialty Pharma reported to Rs 68.85 crore in the quarter ended December 2024 as against net loss of Rs 130.16 crore during the previous quarter ended December 2023. Sales rose 598.38% to Rs 392.56 crore in the quarter ended December 2024 as against Rs 56.21 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales392.5656.21 598 OPM %36.48-18.68 - PBDT102.78-35.36 LP PBT34.02-54.88 LP NP-68.85-130.16 47 Powered by Capital Market - Live News

OneSource Specialty Pharma will hold a meeting of the Board of Directors of the Company on 29 January 2025.Powered by Capital Market - Live News

The equity shares of Onesource Specialty Pharma (Scrip Code: 544292) are listed effective 24 January 2025 and admitted to dealings on the Exchange in the list of ``T`` Group SecuritiesPowered by Capital Market - Live News